Short Interest in Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Drops By 28.6%

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the target of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 2,000 shares, a decrease of 28.6% from the January 31st total of 2,800 shares. Based on an average daily trading volume, of 700 shares, the days-to-cover ratio is presently 2.9 days.

Hikma Pharmaceuticals Price Performance

HKMPY remained flat at $54.80 during mid-day trading on Tuesday. 320 shares of the company’s stock were exchanged, compared to its average volume of 849. Hikma Pharmaceuticals has a 1 year low of $46.16 and a 1 year high of $59.26. The business has a 50-day moving average of $53.89 and a 200 day moving average of $51.61.

Hikma Pharmaceuticals Increases Dividend

The company also recently declared a dividend, which will be paid on Monday, May 12th. Investors of record on Friday, March 21st will be issued a dividend of $0.94 per share. The ex-dividend date of this dividend is Friday, March 21st. This is a boost from Hikma Pharmaceuticals’s previous dividend of $0.62. Hikma Pharmaceuticals’s payout ratio is 10.34%.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.